Clinical trial
Colchicine Effect on Perivascular Inflammation Index on Coronary CTA(COPIX Trial)
NCT05347316 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Colchicine Effect on Perivascular Inflammation Index on Coronary CTA(COPIX Trial)
- Lead sponsor
- University of Sao Paulo General Hospital
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- March 7, 2022
- Completion date
- March 7, 2025
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis, coronary disease, inflammatory response